Invention Grant
- Patent Title: Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes
-
Application No.: US14971424Application Date: 2015-12-16
-
Publication No.: US11267924B2Publication Date: 2022-03-08
- Inventor: Pradeep K. Dhal , Robert J. Miller , Steven C. Polomoscanik , Philip Just Larsen , Thomas Huebschle , Thorsten Schmidt , Ian Davison , Peter D. McDonnell , Chinyere Agbugba
- Applicant: GENZYME CORPORATION
- Applicant Address: US MA Cambridge
- Assignee: GENZYME CORPORATION
- Current Assignee: GENZYME CORPORATION
- Current Assignee Address: US MA Cambridge
- Agent Nicholas P. Triano, III
- Main IPC: C08F226/04
- IPC: C08F226/04 ; C08F299/00 ; C08F8/00 ; A61K31/785 ; A61K45/06 ; A61K31/787 ; C08F26/04
Abstract:
Polydiallylamine copolymers are copolymers comprising monomers of polydiallylamine and either polyvinlyamine or polyallylamine. Polydiallylamine copolymers are often crosslinked. The polydiallyamine copolymers are useful as pharmaceutical compositions and may be used in the treatment of type 2 diabetes and for mitigating the complications of type 2 diabetes.
Public/Granted literature
- US20160177019A1 CROSSLINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES Public/Granted day:2016-06-23
Information query
IPC分类:
